Blackstone Inc Ngm Biopharmaceuticals Inc Transaction History

Blackstone Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $1.1 Million - $1.83 Million	104,432 New	104,432 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $3.26 Million - $4.16 Million	-188,752 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$20.15 - $26.19 $3.8 Million - $4.94 Million	188,752 New	188,752 $3.97 Million
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $130,900 - $181,900	-10,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $125,600 - $166,000	10,000 New	10,000 $146,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.